Document is current
Any future updates will be listed below
-
Authors
Köhrer, Sebastian
Brand, Maximilian Lukas
Leidner, Viola
Zimmer, Holger
Langel, Andrea
Langel, Jessica
Michl, Patrick
Mohr, Isabelle
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 8 February 2026
Accepted: 13 April 2026
First Online: 20 April 2026
Declarations
:
: The retrospective data collection was approved by the Ethics Committee of the University of Heidelberg (protocol number: S-565/2011 and S-546/2020), which complied with the provisions of the Good Clinical Practice guidelines and the Declaration of Helsinki and local laws and fulfilled Regulation (EU) 2016/679 of the European Parliament and the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data (ID number DSAN854-A-OS/5). Proof of informed consent is available upon request from the corresponding author [I Mohr].Written informed consent to participate in this study was obtained from all individual participants included in the study.
: Written informed consent for the procedure and management was obtained from all individual participants included in the study.
: SK, MB, VL, HZ, AL and JL declare no COI. PM received Honoria for lectures from AstraZeneca, Falk and Abbvie. IM advises for Univar, Orphalan and MetaLead, received travel grants from Univar, is Principal Investigator on sponsored studies by Univar and received speaker’s fees from Univar and Orphalan.
